IGF1R Inhibitors Improved Mouse Healthspan but Raised Safety Concerns
TL;DR: A 2026 mouse preprint in bioRxiv reported that small-molecule IGF1R inhibitors, drugs that block insulin-like growth factor 1 receptor signaling, protected several healthspan measures in aging mice, but the tested compounds also carried major safety and drug-development problems. Key Findings 150 aging mice: Researchers assigned 55-week-old C57BL/6 mice to control diet, PPP, or NVP-ADW742, …
